Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Zahra Majd, Anjana Mohan, Michael L Johnson, Ekere J Essien, Jamie C Barner, Omar Serna, Esteban Gallardo, Marc L Fleming, Nancy Ordonez, Marcia M Holstad & Susan M Abughosh. (2022) Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention. Patient Preference and Adherence 16, pages 2739-2748.
Read now
Read now
Wenjie Zhang, Tony B Amos, Stephen W Gutkin, Nicole Lodowski, Emma Giegerich & Kruti Joshi. (2018) A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States. ClinicoEconomics and Outcomes Research 10, pages 309-320.
Read now
Read now
Jalpa A. Doshi, Pengxiang Li, Sunita Desai & Steven C. Marcus. (2017) Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Journal of Medical Economics 20:12, pages 1252-1260.
Read now
Read now
Hamiza Aziz, Ernieda Hatah, Mohd Makmor Bakry & Farida Islahudin. (2016) How payment scheme affects patients’ adherence to medications? A systematic review. Patient Preference and Adherence 10, pages 837-850.
Read now
Read now
Peter M Haddad, Cecilia Brain & Jan Scott. (2014) Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Related Outcome Measures 5, pages 43-62.
Read now
Read now
Kimberly M Shuler. (2014) Approaches to improve adherence to pharmacotherapy in patients with schizophrenia. Patient Preference and Adherence 8, pages 701-714.
Read now
Read now
Colleen A McHorney, Ning Jackie Zhang, Timothy Stump & Xiaoquan Zhao. (2012) Structural equation modeling of the proximal–distal continuum of adherence drivers. Patient Preference and Adherence 6, pages 789-804.
Read now
Read now
Articles from other publishers (19)
Ronaldo Portela, Milton Leonard Wainberg, Saulo Castel, Helian Nunes de Oliveira & Cristina Mariano Ruas. (2022) Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics. BMC Psychiatry 22:1.
Crossref
Crossref
Nam Ji Eum & Seung Hyun Kim. (2022) The Role of Information and Communications Technology Policies and Infrastructure in Curbing the Spread of the Novel Coronavirus: Cross-country Comparative Study. JMIR Public Health and Surveillance 8:1, pages e31066.
Crossref
Crossref
Rwnk Kadhim Jwad, Dheyaa Jabbar Kadhim, Mohammed Hadi Munshed Alosami & Laith G. Shareef. (2022) Medication-related burden among Iraqi patients with rheumatoid arthritis: An observational study. F1000Research 11, pages 1047.
Crossref
Crossref
Miquel Serra‐Burriel, Isabel Hurtado, Gabriel Sanfélix‐Gimeno, Aníbal García‐Sempere & Salvador Peiró. (2021) Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment. Clinical Pharmacology & Therapeutics 110:6, pages 1490-1497.
Crossref
Crossref
Aleksi Hamina, Antti Tanskanen, Jari Tiihonen & Heidi Taipale. (2020) Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia. Medical Care 58:9, pages 763-769.
Crossref
Crossref
Katarzyna Kolasa & Marta Kowalczyk. (2017) The effects of payments for pharmaceuticals: a systematic literature review. Health Economics, Policy and Law 14:03, pages 337-354.
Crossref
Crossref
Yuh-Lin Gan & Claire L. O’Reilly. (2018) Community pharmacists’ attitudes and opinions towards supplying clozapine. International Journal of Clinical Pharmacy 40:5, pages 1116-1130.
Crossref
Crossref
Óskar Hálfdánarson, Helga Zoëga, Lise Aagaard, Miquel Bernardo, Lena Brandt, Anna Coma Fusté, Kari Furu, Kristina Garuoliené, Falk Hoffmann, Krista F. Huybrechts, Luuk J. Kalverdijk, Koji Kawakami, Helle Kieler, Takuya Kinoshita, Melisa Litchfield, Soffy C. López, Jorge E. Machado-Alba, Manuel E. Machado-Duque, Mufaddal Mahesri, Prasad S. Nishtala, Sallie-Anne Pearson, Johan Reutfors, Leena K. Saastamoinen, Izumi Sato, Catharina C.M. Schuiling-Veninga, Yu-Chiau Shyu, Svetlana Skurtveit, Hélène Verdoux, Liang-Jen Wang, Corinne Zara Yahni & Christian J. Bachmann. (2017) International trends in antipsychotic use: A study in 16 countries, 2005–2014. European Neuropsychopharmacology 27:10, pages 1064-1076.
Crossref
Crossref
C. J. Bachmann, L. Aagaard, M. Bernardo, L. Brandt, M. Cartabia, A. Clavenna, A. Coma Fusté, K. Furu, K. Garuoliené, F. Hoffmann, S. Hollingworth, K. F. Huybrechts, L. J. Kalverdijk, K. Kawakami, H. Kieler, T. Kinoshita, S. C. López, J. E. Machado‐Alba, M. E. Machado‐Duque, M. Mahesri, P. S. Nishtala, D. Piovani, J. Reutfors, L. K. Saastamoinen, I. Sato, C. C. M. Schuiling‐Veninga, Y.‐C. Shyu, D. Siskind, S. Skurtveit, H. Verdoux, L.‐J. Wang, C. Zara Yahni, H. Zoëga & D. Taylor. (2017) International trends in clozapine use: a study in 17 countries. Acta Psychiatrica Scandinavica 136:1, pages 37-51.
Crossref
Crossref
Yuko MizunoLinda BeerPing HuangEmma L. Frazier. (2017) Factors Associated with Antiretroviral Therapy Adherence Among Transgender Women Receiving HIV Medical Care in the United States. LGBT Health 4:3, pages 181-187.
Crossref
Crossref
Peggy El-Mallakh & Jan Findlay. (2016) Improving Treatment Adherence in Schizophrenia. Current Treatment Options in Psychiatry 3:2, pages 119-132.
Crossref
Crossref
Amresh Shrivastava, Avinash De Sousa, Sushma Sonavane & Nilesh Shah. (2016) Resilience Improves Neurocognition and Treatment Outcomes in Schizophrenia: A Hypothesis. Open Journal of Psychiatry 06:02, pages 173-187.
Crossref
Crossref
Adem Sav, Michelle A. King, Jennifer A. Whitty, Elizabeth Kendall, Sara S. McMillan, Fiona Kelly, Beth Hunter & Amanda J. Wheeler. (2015) Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expectations 18:3, pages 312-324.
Crossref
Crossref
Réme Mountifield, Jane M. Andrews, Antonina Mikocka-Walus & Peter Bampton. (2014) Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 8:12, pages 1723-1729.
Crossref
Crossref
Jennifer A. Whitty, Simon Stewart, Melinda J. Carrington, Alicia Calderone, Thomas Marwick, John D. Horowitz, Henry Krum, Patricia M. Davidson, Peter S. Macdonald, Christopher Reid & Paul A. Scuffham. (2013) Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? Trial. PLoS ONE 8:3, pages e58347.
Crossref
Crossref
Abhijit S Gadkari & Colleen A McHorney. (2012) Unintentional non-adherence to chronic prescription medications: How unintentional is it really?. BMC Health Services Research 12:1.
Crossref
Crossref
Marco DiBonaventura, Susan Gabriel, Leon Dupclay, Shaloo Gupta & Edward Kim. (2012) A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry 12:1.
Crossref
Crossref
Catherine Frogley, David Taylor, Geoff Dickens & Marco Picchioni. (2012) A systematic review of the evidence of clozapine's anti-aggressive effects. The International Journal of Neuropsychopharmacology 15:09, pages 1351-1371.
Crossref
Crossref
Marco daCosta DiBonaventura, Jessica Panish, Debbie Kenworthy, Jan-Samuel Wagner & Riad Dirani. (2010) The association of well-being, productivity and resource use among community-dwelling patients with schizophrenia using atypical antipsychotics. Journal of Pharmaceutical Health Services Research 1:4, pages 181-187.
Crossref
Crossref